investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
In vivo Derived in Silico Model for DDS Optimization
Dieter Haemmerich
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Timo Ten Hagen
Erasmus University Medical Center
Rotterdam, Netherlands
Dieter Haemmerich
Medical University of South Carolina
Charleston, United States
Related projects
Junjie Chen
Fanconi anemia pathway in DNA damage repair
Melanoma of skin
Xuejun Jiang
Mechanisms and Function of Autophagy in Cancer
Melanoma of skin
Paul J. Anderson
Angiogenin-Induced RNA Cleavage in Cancer
Melanoma of skin
Pasi A Janne
Targeting RET in Lung Cancer
Trachea, bronchus and lung
Pathology
Jeremy Allen Goettel
Investigating cross-regulation of the microbiome and mucosal immune system using humanized mice
Colorectum
Arash Hatefi
Bioengineering a Safe and Efficient Vector Technology for Stem Cell Transfection
Melanoma of skin
Ian Lisle Linde
Mechanistic basis of allogeneic IgG-induced tumor eradication
Melanoma of skin
Wenyi Wei
Functional analysis of beta-TRCP in cell cycle control and DNA damage response
Melanoma of skin
Carl D Novina
(PQD1) Evolution of Vemurafenib Resistance in Circulating Melanoma Cells
Melanoma of skin
Pathology